Refining biomarker evaluation in ASD

This commentary reflects on reasonable biomarker expectations in ASD by addressing three key questions: What is a biomarker? What is required for a biomarker in ASD? How can biomarkers be useful in ASD? In addressing these queries, a path forward emerges based on clear definition of the objective fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European neuropsychopharmacology 2021-07, Vol.48, p.34-36
1. Verfasser:	McPartland, James C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Autism spectrum disorder Autism Spectrum Disorder - diagnosis Biomarkers Clinical trials Endpoints Humans
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This commentary reflects on reasonable biomarker expectations in ASD by addressing three key questions: What is a biomarker? What is required for a biomarker in ASD? How can biomarkers be useful in ASD? In addressing these queries, a path forward emerges based on clear definition of the objective for any given ASD biomarker and evaluation of each biomarker relative to current best practices.
ISSN:	0924-977X 1873-7862
DOI:	10.1016/j.euroneuro.2021.03.023